CytoDyn (CYDY.PK) Updates DNA Flu Vaccine
Biomedical corporation CytoDyn Inc. (Pink Sheets: CYDY) recently announced that the laboratory of Dr. Shan Lu at the University of Massachusetts Medical School (UMMS) had provided CytoDyn with updated DNA-based H1 and H3 serotype influenza vaccines for the 2007-2008 flu season, giving the company a much-needed edge in the bio-pharmaceutical industry.According to a recent release, the DNA-based flu vaccines were updated in less than a month and a half - a much shorter amount of time than it would take to update the vaccine using a wild or natural virus - and plans on using both the H1 and H3…